95 related articles for article (PubMed ID: 12973730)
1. Generalizable mass spectrometry mining used to identify disease state biomarkers from blood serum.
Neville P; Tan PY; Mann G; Wolfinger R
Proteomics; 2003 Sep; 3(9):1710-5. PubMed ID: 12973730
[TBL] [Abstract][Full Text] [Related]
2. Protocols for disease classification from mass spectrometry data.
Wagner M; Naik D; Pothen A
Proteomics; 2003 Sep; 3(9):1692-8. PubMed ID: 12973727
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis.
Howard BA; Wang MZ; Campa MJ; Corro C; Fitzgerald MC; Patz EF
Proteomics; 2003 Sep; 3(9):1720-4. PubMed ID: 12973732
[TBL] [Abstract][Full Text] [Related]
4. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 17-protein signature in the serum of lung cancer patients.
Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
[TBL] [Abstract][Full Text] [Related]
6. Peak quantification in surface-enhanced laser desorption/ionization by using mixture models.
Dijkstra M; Roelofsen H; Vonk RJ; Jansen RC
Proteomics; 2006 Oct; 6(19):5106-16. PubMed ID: 16955530
[TBL] [Abstract][Full Text] [Related]
7. A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samples.
Mantini D; Petrucci F; Pieragostino D; Del Boccio P; Sacchetta P; Candiano G; Ghiggeri GM; Lugaresi A; Federici G; Di Ilio C; Urbani A
J Proteomics; 2010 Jan; 73(3):562-70. PubMed ID: 19914411
[TBL] [Abstract][Full Text] [Related]
8. A strategy for the prior processing of high-resolution mass spectral data obtained from high-dimensional combined fractional diagonal chromatography.
Valkenborg D; Thomas G; Krols L; Kas K; Burzykowski T
J Mass Spectrom; 2009 Apr; 44(4):516-29. PubMed ID: 19065607
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of matrix-assisted laser desorption/ionization-time of flight mass spectrometry proteomic profiling: identification of alpha 2-HS glycoprotein B-chain as a biomarker of diet.
Mitchell BL; Yasui Y; Lampe JW; Gafken PR; Lampe PD
Proteomics; 2005 May; 5(8):2238-46. PubMed ID: 15841498
[TBL] [Abstract][Full Text] [Related]
10. A classification model for the Leiden proteomics competition.
Hoefsloot HC; Smit S; Smilde AK
Stat Appl Genet Mol Biol; 2008; 7(2):Article8. PubMed ID: 18312222
[TBL] [Abstract][Full Text] [Related]
11. Decision tree classification of proteins identified by mass spectrometry of blood serum samples from people with and without lung cancer.
Markey MK; Tourassi GD; Floyd CE
Proteomics; 2003 Sep; 3(9):1678-9. PubMed ID: 12973724
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
13. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
[TBL] [Abstract][Full Text] [Related]
14. Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals.
Pecks U; Seidenspinner F; Röwer C; Reimer T; Rath W; Glocker MO
J Am Soc Mass Spectrom; 2010 Oct; 21(10):1699-711. PubMed ID: 20116281
[TBL] [Abstract][Full Text] [Related]
15. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
16. MALDI-MS data analysis for disease biomarker discovery.
Yu W; Wu B; Liu J; Li X; Stone K; Williams KR; Zhao H
Methods Mol Biol; 2006; 328():199-216. PubMed ID: 16785651
[TBL] [Abstract][Full Text] [Related]
17. Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum.
Lilien RH; Farid H; Donald BR
J Comput Biol; 2003; 10(6):925-46. PubMed ID: 14980018
[TBL] [Abstract][Full Text] [Related]
18. [Detection of serum proteins in the patients of lung adenocarcinoma by the method of magnetic bead based sample fractionation and MALDI-TOF-MS].
Liu D; Liu LX; Yuan Q; Li XL; Huang N; Yang XD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 May; 41(3):498-500, 556. PubMed ID: 20629331
[TBL] [Abstract][Full Text] [Related]
19. Proteomic patterns of tumour subsets in non-small-cell lung cancer.
Yanagisawa K; Shyr Y; Xu BJ; Massion PP; Larsen PH; White BC; Roberts JR; Edgerton M; Gonzalez A; Nadaf S; Moore JH; Caprioli RM; Carbone DP
Lancet; 2003 Aug; 362(9382):433-9. PubMed ID: 12927430
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples.
Baggerly KA; Morris JS; Wang J; Gold D; Xiao LC; Coombes KR
Proteomics; 2003 Sep; 3(9):1667-72. PubMed ID: 12973722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
